Advertisement Materia intends to establish catalyst manufacturing plant in Singapore - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Materia intends to establish catalyst manufacturing plant in Singapore

Materia is planning to establish a new catalyst manufacturing and R&D plant in Singapore with initial operating facility of 10 metric tons.

The company expects to commence the construction by the end of this year.

The new plant will feature research, development, and technical service resources In addition to catalyst manufacturing.

The Singapore site will be operated and controlled by Materia’s newly formed subsidiary, Materia Singapore Pte. Ltd.

Materia CEO Michael Giardello said this expansion represents the first step in the strategy to better serve their customers’ needs through regional catalyst supply.